Profile
Ronald W.
Berninger is Chief Scientific Officer and Executive Vice President of CellCyte Genetics Corp.
Dr. Berninger has over 20 years of experience in building research teams and moving products.
He was Vice President and Director of R&D and QA/Regulatory for Genespan Corp.
and Cennapharm Corp.
Dr. Berninger was Senior Scientist and Head of Biochemistry for CellPro.
He was Senior Scientist of NeoRx Corp.
Dr. Berninger was Assistant Professor at the Tufts University School of Medicine from 1980 to 1986.
He was a Fellow, Instructor and Assistant Professor at the John Hopkins University School of Medicine from 1975 to 1980.
He received a BS degree in Chemistry from Drexel University in 1968 and a PhD in Organic Chemistry from the University of Pittsburgh in 1972.
Former positions of Ronald W. Berninger
| Companies | Position | End |
|---|---|---|
| CELLCYTE GENETICS CORPORATION | Chief Tech/Sci/R&D Officer | 2009-09-09 |
Training of Ronald W. Berninger
| Drexel University | Undergraduate Degree |
| University of Pittsburgh | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
CellCyte Genetics Corp.
 CellCyte Genetics Corp. Miscellaneous Commercial ServicesCommercial Services CellCyte Genetics Corp. engaged in the discovery and development of stem cell therapeutic products. It enabled therapeutic advancements to safely deliver stem cells through the patient's own circulatory or vascular system directly into a specific diseased, damaged or dying organ. The company was founded on March 9, 2004 and was headquartered in Freeland, WA. | Commercial Services |
- Stock Market
- Insiders
- Ronald W. Berninger
